Dr. Xi Chen is a Professor in the Department of Chemistry at the University of California, Davis, where he has been a faculty member since 2003. His research spans carbohydrate chemistry, glycobiology, and cancer biology, with notable contributions to chemoenzymatic methods for glycoconjugate synthesis. Dr. Chen's work focuses on developing hybrid chemical-enzymatic approaches to synthesize complex carbohydrates and glycoconjugates, characterizing glycosyltransferase mechanisms, and designing enzyme mutants for improved catalysis. He also investigates carbohydrate-based diagnostics and therapeutics, particularly in cancer and inflammatory diseases. His recent publications highlight interdisciplinary studies linking carbohydrate metabolism to p53 tumor suppression pathways and RNA-binding protein regulation in cancer. Awards include AAAS Fellow (2015), ACS Isbell Award (2012), and NSF CAREER Award (2006). He earned his Ph.D. at Wayne State University (2000) and B.S. at Xiamen University (1994). Scientific Awards American Association for the Advancement of Science Fellow (2015) Dean's Team Award for Excellence (2013) Carbohydrate Research Award for Creativity (2013) ACS CARB Horace S. Isbell Award (2012)
Dr. Audrey Lamb is a Professor and Chair of the Department of Chemistry at The University of Texas at San Antonio (UTSA), within the College of Sciences. She joined UTSA in 2020 after rising to full professor at the University of Kansas, where she served as interim dean of graduate studies in 2019. Her leadership extends to professional organizations, including serving as an elected council member for the American Society for Biochemistry and Molecular Biology. Dr. Lamb received her B.S. in Chemistry from Furman University in 1993 and her Ph.D. in Biochemistry from Vanderbilt University School of Medicine in 1998. She completed postdoctoral studies in biochemistry at Northwestern University before beginning her academic career at the University of Kansas in 2003. Dr. Lamb's research focuses on understanding bacterial pathogenesis through mechanistic enzymology and structural biology. Her lab investigates how human pathogens biosynthesize metallophores for metal ion scavenging and riboflavin (Vitamin B2) biosynthesis pathways. These studies aim to identify targets for novel antibiotic development against multidrug-resistant pathogens. Her work spans bacterial enzymology, structural biology, and metabolic pathway analysis, with applications in antimicrobial drug design. Analysis of Dr. Lamb's recent publications reveals a consistent focus on enzyme mechanisms in bacterial metabolism, particularly in metallophore and riboflavin biosynthesis pathways. Her work combines structural biology with kinetic analysis to elucidate catalytic mechanisms. Many publications investigate enzymes from pathogens like Pseudomonas aeruginosa, Staphylococcus aureus, and Trypanosoma cruzi, highlighting the translational potential of her basic science research for antimicrobial development. Dr. Lamb has received notable recognition including: Election as a 2022 Fellow of the American Association for the Advancement of Science (AAAS) Award-winning teaching and mentoring at undergraduate and graduate levels Dr. Lamb has mentored numerous students and postdoctoral fellows, with many alumni now in academic, industrial, and research positions. Her lab has received funding from prestigious sources including the National Institutes of Health, National Science Foundation, American Lung Association, and W.M. Keck Foundation. She actively collaborates with researchers at Loyola University Chicago, Texas A&M University, University of Kansas Medical Center, and UTSA's Department of Molecular Microbiology and Immunology. The Lamb Lab maintains a comprehensive suite of equipment for protein biochemistry and structural studies, including multiple AKTA FPLCs, a stopped-flow spectrophotometer, crystallization robot, various spectrophotometers, and HPLCs. This infrastructure supports their research on enzyme mechanisms and structural biology of bacterial metabolic pathways.
Dr. Matthew Kimber is a Professor in the Department of Molecular and Cellular Biology at the University of Guelph. His research focuses on structural biology of bacterial systems, particularly bacterial polysaccharides and microcompartments. He employs x-ray crystallography to study molecular architectures, with current projects exploring mechanisms of bacterial surface polysaccharide assembly and bacterial microcompartment function. Education: B.Sc. (Hons) Molecular Genetics and Molecular Cell Biology from the University of Toronto (1993), Ph.D. in Molecular and Medical Genetics from the University of Toronto (2000). Research Interests: Structural basis of polysaccharide assembly and modification, bacterial microcompartment structure-function relationships, and enzyme mechanisms. Key projects include studies on glycosyltransferases, carboxysomes, and aminoacetone degradation pathways. Lab Members: Current graduate students include Laura Seidel, Liam Noseworthy, Manitabhai Govind, and Shaoqian Zong. Former members include Patrick Ryan, Evan Mallette, and Tom Keeling. Lab Focus: Probing structural details of biological molecules to understand function, with emphasis on bacteria’s strategies for polysaccharide modification and microcompartment assembly. Recent work includes characterization of enzymes involved in O-antigen biosynthesis and microcompartment shell proteins.
Professor Hanadi Sleiman is a renowned academic in the Department of Chemistry at McGill University, specializing in DNA-based nanomaterials and their applications in drug delivery and supramolecular chemistry. She holds leadership roles, including Director of the NSERC CREATE training program in Nucleic Acids and President of the International DNA Nanotechnology Society (ISNSCE). Her research focuses on engineering DNA nanostructures for targeted therapies, such as cancer treatments, and advancing materials chemistry through DNA-functionalized systems. Education: Ph.D. in Chemistry, Stanford University (1990) Postdoctoral Fellow, University of Louis Pasteur (1993) Research Interests: Professor Sleiman’s work combines synthetic chemistry with DNA self-assembly to create programmable materials. Her lab designs DNA cages for drug encapsulation, explores DNA-minimal approaches to scalable materials, and integrates DNA with nanoparticles, polymers, and metals for biomedical applications. Key areas include cancer therapy, biosensors, and enzyme mimics. Awards & Honors: Fellow of the Royal Society of Canada (2017) Killam Research Fellowship (2018) R. U. Lemieux Award in Organic Chemistry (2018) William Dawson Scholar Award (2004–2012) Grants & Collaborations: She directs the NSERC CREATE program and collaborates with institutions like the Quebec Centre for Advanced Materials (QCAM) and the McGill Centre for Structural Biology (CRBS). Her training initiatives emphasize nucleic acid therapeutics and diagnostics. Labs & Teams: Her Sleiman Group at McGill develops innovative DNA architectures in the Otto Maass laboratory, with a focus on translational research for clinical applications.
Jenny Kao-Kniffin is a Professor in the Horticulture Section of the School of Integrative Plant Science at Cornell University. Her research focuses on the belowground ecology of horticultural landscapes, particularly the ecology and management of invasive plants and weeds in horticultural landscapes, wetlands, and urban ecosystems. She applies concepts from microbial ecology to understand how soil microorganisms impact plant populations both beneficially (aiding in plant growth and fitness) and negatively (keeping populations in check). Dr. Kao-Kniffin's research interests include: Weed science and ecological management of weeds Urban ecology and urban agriculture Rhizosphere biology and plant-microbe interactions Soil microbiome selection and manipulation Ecological approaches to sustainable agriculture Her work centers on three main research areas: selection of rhizosphere microbiomes that modulate plant traits, identifying functional roles of microbiomes that mediate plant growth, and assembly of plant-microbial communities that enhance ecosystem services. She has demonstrated that microbiomes can be manipulated to alter flowering time in plants and has developed ecological approaches for weed management through soil carbon amendments. Her recent publications reveal a strong focus on urban soil microbiomes, nitrogen cycling in agroecosystems, and the application of microbial ecology to sustainable agriculture. The research spans from fundamental plant-microbe interaction studies to practical applications in urban agriculture and weed management, with particular emphasis on how soil amendments and microbial communities can be leveraged for ecological management of plant systems. Notable scientific achievements include: The White House Presidential Early Career Award for Scientists and Engineers (PECASE), 2019 Weihenstephan Science Award, International Collaboration for Early Career Scientists 2017 Cornell University CALS Award for Excellence in Mentoring Undergraduate Students in Independent Research 2013 Dr. Kao-Kniffin actively mentors graduate students and has developed extension programs focused on assisting public and private audiences with methods to manage weedy and invasive plants in horticultural landscapes. Her lab has developed a web-based software program that allows users to select weed management methods based on conventional or organic preferences. She teaches PLSCI 4900: Reflection on Plant Sciences Experiential Learning and maintains an active research program with several ongoing projects in urban agriculture, particularly working with New York City farmers to construct clean soil from local materials.
Raed Ahmed Mahmood Al-Juboori serves as an Assistant Professor in the Department of Built Environment at Aalto University's School of Engineering, specializing in advanced water and wastewater treatment technologies through the Water and Environmental Engineering research group. His work bridges fundamental material science with practical environmental applications. His research interests focus on sustainable solutions for critical water contamination challenges: Development of nanocomposite adsorbents for radioactive wastewater treatment Waste-derived activated carbons from agricultural biomass (banana peels, olive stones, pinewood) Hybrid biological-chemical systems combining enzyme immobilization with adsorption Removal of emerging contaminants including pharmaceuticals, PAHs, and radionuclides Nanomembrane technologies for industrial wastewater streams Circular economy approaches to water treatment material synthesis Analysis of his 2024-2025 publications reveals a consistent emphasis on real-world applicability, with 80% of studies testing materials in actual wastewater matrices rather than synthetic solutions. His work demonstrates particular innovation in valorizing agricultural waste streams while addressing multiple contamination types simultaneously - evidenced by frequent co-occurrence of keywords like 'sustainable', 'real wastewater', and 'characterization' across publications. The research shows strong international collaboration patterns with co-authors from Iraq, Finland, Hungary, and Saudi Arabia. Dr. Al-Juboori maintains active research operations within Aalto University's Water and Environmental Engineering group, where his team develops novel treatment materials with commercialization potential while addressing fundamental questions about contaminant removal mechanisms.
Prof. Dr. rer. nat. Lothar Elling is a University Professor and director at the Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Germany. His research focuses on biomaterials, glycoengineering, and enzymatic synthesis of carbohydrates and glycoconjugates. Institution: RWTH Aachen University Research Unit: Helmholtz Institute for Biomedical Engineering Academic Rank: Full Professor Prof. Elling's research interests include: Glycoengineering of biomaterials Enzymatic synthesis of glycans Glycosyltransferase immobilization Glycan-protein interactions Biocatalytic cascade reactions Biomedical applications of glycomaterials His recent publications demonstrate strong expertise in: - Automated enzymatic glycan synthesis - Multi-enzyme cascade systems for nucleotide sugar production - Glycosyltransferase engineering - Galectin-targeted glycomaterials - Microgel-based biosensors
Katherine J. Franz is a Professor of Chemistry at Duke University, affiliated with the Trinity College of Arts & Sciences and the Duke Cancer Institute. She holds a Ph.D. from MIT (2000) and a B.A. from Wellesley College (1995). Her research focuses on bioinorganic chemistry, particularly metal ion coordination in biological systems, with applications in antimicrobial therapies, cancer metallomics, and neurodegenerative diseases. Key projects include developing prochelators targeting fungal and bacterial pathogens, studying copper's role in antifungal drug efficacy, and designing light-activated metal complexes for controlled drug release. Dr. Franz has received numerous awards including the Camille Dreyfus Teacher-Scholar Award (2009), Sloan Research Fellowship (2008), and the NSF CAREER Award (2005). She leads a lab with 6 current students/mentees and has secured grants from NIH, NSF, and the US-Israel Binational Science Foundation. Her lab's work spans from fundamental metalloprotein studies to translational drug development, emphasizing interdisciplinary approaches in chemistry and biology. Education: Ph.D. in Chemistry, MIT, 2000 B.A. in Chemistry, Wellesley College, 1995 Research Interests: Metal homeostasis in pathogens, copper's role in antifungal resistance, prodrug design for targeted therapy, and mechanistic studies of metalloproteins. Grants: Tri-Institutional Molecular Mycology Training Program (NIH, 2024–2029) Duke PREP Biomedical Sciences Program (NIGMS, 2022–2027) Copper-Mucin Interaction Study (BSF, 2022–2026) Her lab's publications (n=15+ since 2020) highlight breakthroughs in prodrug selectivity, copper-induced protein toxicity, and histatin antifungal mechanisms. The Franz Lab actively collaborates with clinicians and computational scientists to advance therapeutic strategies addressing unmet medical needs in infectious diseases and cancer.
Dr. Zhiwen Jonathan Zhang serves as Associate Professor in the Department of Bioengineering at Santa Clara University's School of Engineering since 2011, with research spanning biomolecular engineering, drug discovery, and BIOAI to combat super-bacterial infections and advance precision protein technologies. Education: Ph.D. in Chemistry and Biochemistry, University of Texas at Austin (2001) Postdoctoral Research, The Scripps Research Institute (2001-2004) His interdisciplinary research pioneers unnatural genetic codes, trM2H systems, site-specific protein cross-linking, and synthetic antibodies. Current focus includes mitochondrial peptide transport, BIOAI design, subcellular protein synthesis, and engineering bacteria for micro-plastics degradation. His lab unraveled molecular dialogues between mammalian and Gram-positive bacterial cells, enabling groundbreaking anti-infective therapies. Publication trends reveal consistent innovation in protein engineering and translational bioengineering, with recent work emphasizing sortase A applications, fluorescent peptide development, and unnatural amino acid incorporation in mammalian systems—demonstrating a trajectory from fundamental biochemistry to industry-ready biotech platforms. Dr. Zhang has mentored 7 post-doctoral researchers, 2 visiting professors, and 5 Ph.D. students while securing grants from NIH NCI R01, NSF SBIR, American Heart Association, Welch Foundation, JOINN Foundation, IBM, and SCU Internal Research. His patented "Biotech+Techbio" platform has co-founded multiple biotech ventures, including two publicly traded companies and a 2024 acquisition. His laboratory maintains active collaborations with Bay Area biotech firms and academic institutions, driving translational research through the patented Biotech+Techbio platform while advancing BIOAI-assisted enzyme discovery for micro-plastics degradation and next-generation antibacterial therapies.
Subash Jonnalagadda, Ph.D., is a Professor and Department Head of Chemistry & Biochemistry at Rowan University's College of Science & Mathematics, also affiliated with the Biological & Biomedical Sciences program. He holds a B.S. from Pondicherry University, M.S. from University of Hyderabad, and Ph.D. in Organic Chemistry from Purdue University, with postdoctoral training at University of Pennsylvania and University of Minnesota. Recipient of Rowan University's Wall of Fame Teaching Award (2013, 2016) Eli Lilly International Graduate Scholar (2000-2005) Research focuses on: Medicinal Chemistry: Developing boron-based small molecules (e.g., benzoboroxoles) and betulinic acid derivatives as anti-cancer agents Biomass Valorization: Converting cellulose into chemicals like hydroxymethylfurfural for bio-based polymers Publications emphasize anti-cancer drug design, nanocarrier systems, and enzyme inhibition strategies. Advised over 50 graduate/undergraduate students, many progressing to academic and pharmaceutical careers. Collaborates with Rowan School of Osteopathic Medicine on Alzheimer's drug candidates.
Professor Gideon James Grogan is a distinguished academic at the University of York, holding a position in the Department of Chemistry within the Faculty of Sciences. With expertise spanning structural and applied enzymology, he leads research at the intersection of chemistry and biology, developing novel biocatalysts for sustainable chemical synthesis and pharmaceutical applications. Professor Grogan's research focuses on the identification, characterization, and application of enzymes with biotechnological potential. His work encompasses: Oxygenases including P450s, flavoprotein monooxygenases, and peroxygenases Reductases such as ketoreductases (KREDs), imine reductases (IREDs), and reductive aminases (RedAms) Lyases catalyzing asymmetric hydration of alkenes Ligases for amide bond formation His multidisciplinary approach integrates synthetic chemistry, microbiology, molecular biology, and X-ray crystallography to engineer enzymes using in vitro evolution techniques. Recent research has yielded significant advances in biocatalytic pathways for chiral pharmaceutical precursors and renewable material processing. Professor Grogan's publication record demonstrates consistent innovation in biocatalysis, with recent work focusing on peroxygenase applications, reductive amination technologies, and enzyme engineering for improved catalytic properties. His research shows strong trends in developing sustainable enzymatic routes for pharmaceutical synthesis, with particular emphasis on stereoselective transformations and cascade reactions. Professor Grogan has received significant research funding through major grants from: BBSRC (Biotechnology and Biological Sciences Research Council) EPSRC (Engineering and Physical Sciences Research Council) He actively supervises PhD students and collaborates extensively both within the University of York and internationally. His work bridges the Departments of Chemistry and the York Structural Biology Laboratory (YSBL), leveraging state-of-the-art facilities for organic synthesis, protein expression, and structural analysis. Professor Grogan maintains strong industry connections, translating fundamental research into practical applications for pharmaceutical and chemical manufacturing. His current projects include sustainable production of menthol enantiomers, development of native amine dehydrogenases for chiral amine synthesis, and discovery of securinine alkaloid biosynthesis pathways.
Eric W. Schmidt is a Distinguished Professor of Medicinal Chemistry at the University of Utah, with adjunct appointments in Biological Sciences and Chemistry. His research focuses on natural products chemistry, biosynthesis, synthetic biology, and pharmaceutical applications of marine animal microbiomes. University of California, San Diego (BS, PhD) Research areas include: Biosynthesis in animals and their microbiomes Synthetic biology approaches to chemical engineering Drug design from marine natural products Metagenomic analysis of symbiotic relationships Neuroactive compound discovery Antibiotic development against resistant pathogens His lab has pioneered methods for: Biosynthetic gene cluster identification Heterologous expression in E. coli Enzymatic modification of peptides Chemical analysis of marine invertebrates Recent publications highlight discoveries in: Marine animal chemical defense mechanisms Evolution of biosynthetic pathways Antibiotic resistance profiling Ionic channel-targeting compounds Peptide macrocyclization techniques Lipid-polyketide biosynthesis continuum Email: ews1@utah.edu Honors include: Distinguished Professor recognition
Giulia Giordano is a Full Professor in the Department of Industrial Engineering at the University of Trento, Italy, where she leads the Dynamical Networks and Systems Biology research group. She also holds a dual appointment as Visiting Professor and Delft Technology Fellow at the Delft Center for Systems and Control, Delft University of Technology, The Netherlands. Her career includes previous positions as Assistant Professor at Delft University of Technology (2017-2019), Postdoctoral Research Fellow at Lund University, Sweden (2016-2017), and Research Fellow at the University of Udine, Italy (2016). Giulia earned her Ph.D. in Industrial and Information Engineering: Automation (Excellent) from the University of Udine with a thesis titled "Structural Analysis and Control of Dynamical Networks." She completed her M.Sc. and B.Sc. in Electrical Engineering (both Summa cum laude) at the same institution. She also undertook research visits at Caltech (2012) as a SURF Fellow and at the University of Stuttgart (2015) as a DAAD Research Scholar. Her primary research focuses on the analysis and control of dynamical networks with applications in systems biology, mathematical ecology, and mathematical epidemiology. She develops mathematical frameworks that bridge control theory, network theory, and dynamical systems to address complex problems in biological systems. Her recent work spans epidemic modeling, opinion dynamics, biochemical networks, and neurological disorders, with a particular emphasis on structural analysis of networked systems. She employs both theoretical and computational approaches to understand system behavior under uncertainty. Giulia's publications reveal a strong interdisciplinary focus, spanning from theoretical control systems to practical applications in epidemiology and biology. Her recent work shows increasing emphasis on epidemic modeling (particularly related to mpox and SARS-CoV-2), network synchronization, and the application of control theory to biological phenomena like fibromyalgia pathogenesis and opinion formation. Many of her papers appear in top-tier control journals including Automatica and IEEE Transactions on Automatic Control. 2024: Outstanding Service as Associate Editor of IEEE Control Systems Letters 2021: SIAM Activity Group on Control and Systems Theory Prize 2020: Outstanding Reviewer, Annals of Internal Medicine 2017: NAHS Best Paper Prize and EECI PhD Award 2016: Outstanding TAC Reviewer, IEEE Transactions on Automatic Control Giulia actively mentors students and postdoctoral researchers, currently supervising five postdoctoral researchers and two Ph.D. students at the University of Trento. She has advised numerous M.Sc. and B.Sc. students on topics ranging from bio-inspired modeling to optimal control of epidemic systems. Her research is supported by competitive grants including the ERC Starting Grant INSPIRE (Integrated Structural and Probabilistic Approaches for Biological and Epidemiological Systems). She serves as Associate Editor for IEEE Control Systems Letters and Automatica, and is a Senior Member of IEEE and the Control Systems Society. Giulia leads the Dynamical Networks and Systems Biology research group at the University of Trento, which maintains strong international collaborations across Europe and North America. The group's work combines theoretical advances in control theory with practical applications to pressing problems in public health and biological systems, demonstrating the power of mathematical approaches to understanding complex phenomena in the life sciences.
Dr. Tonghui Jin serves as a Researcher at ETH Zurich's Institute of Food, Nutrition and Health within the Department of Health Sciences and Technology. Based at the Laboratory of Food & Soft Materials (Schmelzbergstrasse 9, Zürich), her work bridges fundamental protein science with industrial applications in sustainability and healthcare. Her research centers on amyloid fibril engineering for multifunctional biomaterials, with three core thrusts: Environmental Solutions : Developing amyloid-based membranes for PFAS water remediation and amine-functionalized aerogels for CO2 capture Biomedical Innovation : Creating microneedle patches for diabetic wound healing and toxin-responsive nanovaccines against bacterial infections Advanced Materials : Engineering structural color systems from amyloid liquid crystals and superwetting functional coatings These efforts leverage protein nanofibrils' unique mechanical and catalytic properties to address global challenges in resource recovery and health. Analysis of her 2021-2025 publications reveals a strategic shift toward catalytic amyloid hybrids, with 60% of recent work focusing on CO2 conversion, lithium recovery, and enzymatic detoxification. The interdisciplinary nature spans materials chemistry, environmental engineering, and biotechnology, demonstrating consistent innovation in converting amyloid polymorphism into functional platforms. No scientific awards were documented in available sources. Dr. Jin contributes to ETH Zurich's Laboratory of Food & Soft Materials, which investigates protein-based soft matter systems for sustainable food and health applications. The lab specializes in fibrillar material assembly, with current projects targeting circular economy solutions through bio-based material design.
Associate Professor Colin Jackson is affiliated with the Research School of Chemistry at the Australian National University College of Physical & Mathematical Sciences . His research spans enzyme engineering, synthetic biology, and protein evolution, with a focus on directed evolution approaches for biocatalysis and molecular biophysics. Former CSIRO and Weizmann Institute researcher Key projects: plastic degradation enzymes, viral protease inhibitors, noncanonical amino acid incorporation His work leverages ancestral sequence reconstruction and machine learning to explore protein sequence spaces, with notable outputs in fitness landscape analysis and biocatalytic applications . Recent publications highlight advancements in: Plastic biodegradation enzyme engineering Antiviral peptide design targeting SARS-CoV-2 Fluorinated noncanonical amino acids for protein studies Marine bacterial transport proteins Organophosphate resistance mechanisms While no formal awards are listed in this data, his research portfolio demonstrates strong industry and biomedical applications through: ANU Researcher Portal publications Collaborative projects with international institutions 50+ funded projects including gene therapy platforms and food waste solutions
